Mantle Cell Lymphoma | Tumor

CURE’s mantle cell lymphoma (MCL) page features the latest cancer news and updates on mantle cell lymphoma Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in mantle cell lymphoma.

Managing Mantle Cell Lymphoma (MCL) after Relapsed on First Treatment

An interview with Dr. Luhua (Michael) Wang, MD, Department of Lymphoma and Myeloma, Division of Cancer Medicine, MD Anderson Cancer Center

Keep Inspiring

Don’t let your disease define you

CAR-T Cell Therapy Shows Potential in Relapsed/Refractory Mantle Cell Lymphoma

June 12th 2019, 7:00pm

Article

Treatment with lisocabtagene maraleucel, also known as liso-cel, demonstrated clinical activity and appeared tolerable among patients with relapsed/refractory mantle cell lymphoma.

Researcher Highlights the Need for Curative Approach to Mantle Cell Lymphoma Treatment

May 20th 2019, 7:06pm

Article

While many advances have been made in the treatment landscape of MCL, the need for curative treatment options may be where future research goes.

Newer Drug Combinations Offer Hope to Those With Mantle Cell Lymphoma

May 17th 2019, 9:40pm

Article

One expert discusses the significance of newer drugs and the role they play in helping patients with relapsed or refractory disease.

Investigational Drug May Help Drug Resistance in Mantle Cell Lymphoma Treatment

May 17th 2019, 12:11am

Article

A small molecule drug may help to overcome resistance to Imbruvica in patients with MCL, according to preclinical study findings from The University of Texas MD Anderson Cancer Center.

Despite Advances, Many Questions Remain in Mantle Cell Lymphoma Treatment

April 9th 2019, 7:00pm

Article

Izidore S. Lossos, M.D., discussed how questions remain on how to find the least toxic therapies that will prolong survival in both young and elderly patients with mantle cell lymphoma.

Study Examines Combination Regimen for Treating CINV During and After Chemo

April 8th 2019, 3:00pm

Article

A recent clinical trial is examining the combination regimen of netupitant plus palonosetron (NEPA), with hopes that it can curb nausea and vomiting both before and after chemotherapy in patients with peripheral T-cell lymphoma, Hodgkin lymphoma, mantle cell lymphoma and diffuse large B-cell lymphoma.

Paging Dr. Web

March 21st 2019, 5:47pm

Article

Surprise! You can’t believe everything you read on the internet!

Therapies and Challenges in the Evolving Treatment of Mantle Cell Lymphoma

March 15th 2019, 5:00pm

Article

While it is an exciting time for the treatment of mantle cell lymphoma (MCL), challenges still remain, according to Andre Goy, M.D., MS.

Panel Finds Value in Certain Maintenance Therapies for Patients with Lymphoma

March 14th 2019, 5:43pm

Article

With the evolving landscape of maintenance therapies to treat patients with lymphoma following auto-HCT, a panel consensus recommended four grade A options for physicians to utilize.

Oral Blood Thinner May Reduce Blood Clots in High-Risk Patients with Cancer

March 8th 2019, 7:12pm

Article

The oral blood thinner Xarelto (rivaroxaban) significantly reduced blood clots for high-risk patients with cancer being treated in the outpatient setting, according to results from the CASSINI trial.